0
Obstructive Lung Diseases: COPD Exacerbations |

Usefulness of Procalcitonin as a Prognostic Marker in Critically Ill Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease FREE TO VIEW

Xubin Huang, MD; Jun Zhang, MD; Xinyan Huang, MD; Yanzhu Chen, MD; Mian Zeng, MD
Author and Funding Information

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;149(4_S):A366. doi:10.1016/j.chest.2016.02.381
Text Size: A A A
Published online

SESSION TITLE: COPD Exacerbations

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM

PURPOSE: The usefulness of procalcitonin (PCT) as a prognostic marker in critically ill patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is controversial. The present study prospectively detected whether PCT measured on intensive care unit (ICU) admission is predictive of 28-day mortality in a cohort of critically ill patients with AECOPD.

METHODS: A total of 90 consecutive patients with AECOPD admitted to the medical ICU in a tertiary university hospital, during a 37-month period between June 2012 and June 2015, were assessed. Patients with major surgery in a month were excluded.

RESULTS: The median age was 76 yr (range, 43-89 yr; IQR, 69-81), and 87.8% of the patients were male. 28 patients required exclusively non-invasive ventilation, 44 required exclusively invasive ventilation, 8 required both non-invasive and invasive ventilation, and 10 required only oxygen therapy. The median level of PCT on ICU admission was 0.30ng/mL (range, 0.02-120.00ng/mL; IQR, 0.10-1.80ng/mL), and the median APACHE II score was 19 (range, 10-43). The 28-day mortality rate was 35.6%. The 28-day survivors did show significantly decreased levels of PCT compared with non-survivors (0.25 ng/mL [range, 0.02-120.00 ng/mL] vs. 0.56ng/mL [0.05-33.44 ng/mL], Z=−2.55, P=0.01). In prediction of 28-day mortality, the area under the curve (AUC) for PCT was 0.66 (95% confidence interval [CI], 0.55-0.77) and APACHE II score was 0.68 (95% CI, 0.55-0.81). AUC was 0.68 (95%CI, 0.55-0.81) when PCT was combined with APACHE II score.

CONCLUSIONS: The 28-day survivors did show significantly decreased levels of PCT compared with non-survivors on ICU admission in critically ill patients with AECOPD in a medical ICU. PCT on ICU admission might be predictive for 28-day mortality in patients with AECOPD. Moreover, combining PCT with APACHE II score added little additional power in predicting 28-day mortality in this cohort of critically ill patients with AECOPD.

CLINICAL IMPLICATIONS: The PCT level might be used as a predictor of 28-day mortality in critically ill patients with AECOPD in the medical ICU. Little additional power was added when PCT was combined with APACHE II score.

DISCLOSURE: The following authors have nothing to disclose: Xubin Huang, Jun Zhang, Xinyan Huang, Yanzhu Chen, Mian Zeng

No Product/Research Disclosure Information


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543